A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MMM

Search Conditions:
Search Keyword : MMM
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: MMM
Appearance Frequency: 492 time(s)
Long forms: 130

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
myelofibrosis with myeloid metaplasia
(155 times)
Hematology
(107 times)
PV (29 times)
ET (24 times)
CML (11 times)
1975 [Subacute myelogenous leukemia with Phildelphia chromosome].
May Measurement Month
(36 times)
Vascular Diseases
(1 time)
BP (33 times)
CVD (2 times)
HTN (2 times)
2017 May Measurement Month: a new joint global initiative by the International Society of Hypertension and the World Hypertension League to raise awareness of raised blood pressure.
mixed matrix membrane
(30 times)
Biomedical Engineering
(8 times)
HPLC (3 times)
ABE (2 times)
AC (2 times)
2011 Mixed matrix membrane incorporated with large pore size halloysite nanotubes (HNT) as filler for gas separation: experimental.
metastatic malignant melanoma
(17 times)
Neoplasms
(11 times)
PMM (2 times)
AI (1 time)
AIC (1 time)
1990 A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma.
Multifocal multiphoton microscopy
(17 times)
Ophthalmology
(8 times)
MAPMT (3 times)
SLM (3 times)
SNR (3 times)
2000 Live cell imaging by multifocal multiphoton microscopy.
medium-mass molecules
(13 times)
Medicine
(2 times)
MDA (3 times)
AA (1 time)
AOA (1 time)
1989 [Middle molecules as an indicator of the degree of disruption of blood coagulation in hemophilia].
mucosal malignant melanoma
(12 times)
Neoplasms
(5 times)
RR (2 times)
RT (2 times)
CI (1 time)
1999 Primitive sinonasal malignant mucosal melanoma: description of a case treated with radiotherapy (0-7-21 regimen).
magnetic marker monitoring
(11 times)
Pharmacology
(7 times)
GI (5 times)
ER (2 times)
RCC (2 times)
1999 Magnetic marker monitoring of esophageal, gastric and duodenal transit of non-disintegrating capsules.
myeloid metaplasia with myelofibrosis
(11 times)
Hematology
(5 times)
PV (4 times)
ET (3 times)
HT (2 times)
1977 Ph1-positive polycythemia vera.
10  multimodality monitoring
(9 times)
Critical Care
(6 times)
ICP (3 times)
SBI (3 times)
CBF (2 times)
2013 Multimodality monitoring in the neurointensive care unit: a special perspective for patients with stroke.
11  marginal metallophilic macrophages
(7 times)
Microbiology
(2 times)
MZM (5 times)
MZ (3 times)
DCs (2 times)
1995 Brucella abortus causes an accelerated repopulation of the spleen and liver of mice by macrophages after their liposome-mediated depletion.
12  Marijuana Motives Measure
(7 times)
Substance-Related Disorders
(7 times)
CFA (2 times)
ARCI (1 time)
CAST (1 time)
2007 Marijuana use motives: concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers.
13  Methadone medical maintenance
(6 times)
Substance-Related Disorders
(4 times)
--- 2000 Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice--a summary report (1983-1998).
14  mitozantrone, methotrexate and mitomycin C
(6 times)
Neoplasms
(5 times)
TTP (2 times)
CG (1 time)
CRs (1 time)
1991 A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
15  mixture model method
(6 times)
Medical Informatics
(3 times)
SAM (4 times)
EB (2 times)
FDR (1 time)
2003 Modified nonparametric approaches to detecting differentially expressed genes in replicated microarray experiments.
16  masticatory muscle myositis
(5 times)
Veterinary Medicine
(3 times)
EMG (1 time)
IM (1 time)
IMs (1 time)
1995 Muscle fibre expression of transforming growth factor-beta 1 and latent transforming growth factor-beta binding protein in canine masticatory muscle myositis.
17  malignant mucosal melanoma
(4 times)
Neoplasms
(3 times)
ACC (1 time)
ADC (1 time)
C-ion RT (1 time)
1998 Primary malignant melanoma of the mucous membranes.
18  membrane, magnesium, mitosis
(4 times)
Metabolism
(1 time)
--- 2005 Magnesium: The missing element in molecular views of cell proliferation control.
19  multi-male mating
(4 times)
Environmental Health
(1 time)
--- 2002 Multi-male mating, probability of conception, and litter size in the prairie vole (Microtus ochrogaster).
20  mechanical middle ear model
(3 times)
Otolaryngology
(2 times)
CAD (1 time)
CoMEP (1 time)
LDV (1 time)
1998 [Measuring vibration properties of middle ear implants with the mechanical middle ear model. Initial results].
21  Medical Management
(3 times)
Education
(2 times)
ACPE (1 time)
2001 Carnegie Mellon University's MMM program: management education for 21st-century physicians.
22  Modified Monash Model
(3 times)
Public Health
(2 times)
AHPRA (1 time)
ASGC-RA (1 time)
CIs (1 time)
2017 The changing landscape of physiotherapy student clinical placements: An exploration of geographical distribution andstudent performance across settings.
23  Multiple Mapping Method
(3 times)
Biochemistry
(2 times)
MT (1 time)
2006 Multiple mapping method: a novel approach to the sequence-to-structure alignment problem in comparative protein structure modeling.
24  multiple molecular markers
(3 times)
Virology
(2 times)
CTV (3 times)
CC (1 time)
CCPP (1 time)
2005 Assessment of sequence diversity in the 5'-terminal region of Citrus tristeza virus from India.
25  malignant melanoma
(2 times)
Neoplasms
(1 time)
BMN (1 time)
cCD44std (1 time)
cICAM-1 (1 time)
1993 Proliferative activity in Spitz's naevi compared with other melanocytic skin lesions.
26  Malteser Migranten Medizin
(2 times)
Public Health
(1 time)
--- 2015 [Health Status of Persons without Health Insurance and of Undocumented Migrants: Analysis of Data from the Malteser Migranten Medizin (MMM) in Munich, Germany].
27  maternal morbidity and mortality
(2 times)
Wounds and Injuries
(1 time)
E-utilities (1 time)
ES (1 time)
ICU (1 time)
2016 Perioperative risk factors impact outcomes in emergency versus nonemergency surgery differently: Time to separate our national risk-adjustment models?
28  mean molecular mass
(2 times)
Biotechnology
(2 times)
DOT (2 times)
OTR (2 times)
SAPR (1 time)
2007 The oxygen transfer rate influences the molecular mass of the alginate produced by Azotobacter vinelandii.
29  metastatic melanoma
(2 times)
Pathology
(2 times)
Arg (1 time)
BM (1 time)
BN (1 time)
1999 PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
30  methotrexate, mitomycin-c and mitoxantrone
(2 times)
Allergy and Immunology
(1 time)
CT (2 times)
MBC (2 times)
beta-IFN (1 time)
1995 Beta-interferon, retinoids and tamoxifen as maintenance therapy in metastatic breast cancer. A pilot study.
31  methylmethacrylate monomer
(2 times)
General Surgery
(1 time)
--- 1977 Some aspects of pulmonary excretion of methylmethacrylate monomer (MMM) in dogs.
32  mitomycin-C, mitoxantrone, and methotrexate
(2 times)
Neoplasms
(2 times)
--- 1992 Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexate.
33  modified minimal medium
(2 times)
Endocrinology
(1 time)
E. coli (1 time)
LB (1 time)
RM (1 time)
1990 The modified minimal model: application to measurement of insulin sensitivity in children.
34  multilevel measurement model
(2 times)
Statistics as Topic
(2 times)
CCREM (1 time)
HGLM (1 time)
2005 The multilevel measurement model: introduction to the special issue.
35  multimarker methods
(2 times)
Neoplasms
(1 time)
BA (1 time)
BL (1 time)
LD (1 time)
2014 Next generation modeling in GWAS: comparing different genetic architectures.
36  Magnetic Micro-Machines
(1 time)
Biomedical Engineering
(1 time)
--- 2008 Fabrication of new Magnetic Micro-Machines for minimally invasive surgery.
37  major maternal morbidity
(1 time)
Hypertension, Pregnancy-Induced
(1 time)
SPRE (1 time)
2012 PP039. The importance of intentionally considering class 1 HELLP syndrome outcomes versus all other categories of HELLP syndrome or severe preeclampsia.
38  Making More of Math
(1 time)
Behavioral Sciences
(1 time)
EF (1 time)
2017 The DREME Network: Research and Interventions in Early Childhood Mathematics.
39  male-male mounting
(1 time)
Natural Science Disciplines
(1 time)
--- 2017 Increased Male-Male Mounting Behaviour in Desert Locusts during Infection with an Entomopathogenic Fungus.
40  malignant mixed mesodermal
(1 time)
Gynecology
(1 time)
LMS (1 time)
1984 Uterine sarcomas: a clinicopathologic study, 1965-1981.
41  Malignant myxoid melanoma
(1 time)
Dermatology
(1 time)
--- 2002 Myxoid melanoma: immunohistochemical studies and a review of the literature.
42  mammillary bodies
(1 time)
Brain
(1 time)
FR (1 time)
IPN (1 time)
LHRH (1 time)
1983 Effects of lesions of putative LHRH-containing pathways and midbrain nuclei on lordotic behavior and luteinizing hormone release in ovariectomized rats.
43  man-made mineral fibers
(1 time)
Environmental Health
(1 time)
--- 1983 Macrophage functions after exposure to mineral fibers.
44  manual micromanipulator
(1 time)
Otolaryngology
(1 time)
P/A (1 time)
RMC (1 time)
2015 The application of robotics to microlaryngeal laser surgery.
45  manual morcellation through mini-laparotomy
(1 time)
Gynecology
(1 time)
MMV (1 time)
PM (1 time)
2016 Comparison of methods of morcellation: manual versus power.
46  manualized Matrix Model
(1 time)
Substance-Related Disorders
(1 time)
OTP (1 time)
2012 Comparison of buprenorphine treatment for opioid dependence in 3 settings.
47  many-to-many image superpixel matching
(1 time)
Cybernetics
(1 time)
--- 2014 Many-to-many superpixel matching for robust tracking.
48  Mapping, Measuring, Monitoring
(1 time)
Medicine
(1 time)
MRV (1 time)
2016 Moving from Measuring, Reporting, Verification (MRV) of Forest Carbon to Community Mapping, Measuring, Monitoring (MMM): Perspectives from Mexico.
49  Marginalized Multilevel Models
(1 time)
Pharmacology
(1 time)
GLMM (1 time)
2019 Marginalized models for right-truncated and interval-censored time-to-event data.
50  marine minimal medium
(1 time)
Environmental Health
(1 time)
Glt (1 time)
2009 Nitrogen regulates chitinase gene expression in a marine bacterium.
51  marker motion magnitude
(1 time)
Radiology
(1 time)
AP (1 time)
eNAL (1 time)
LR (1 time)
2017 Assessment with cone-beam computed tomography of intrafractional motion and interfractional position changes of resectable and borderline resectable pancreatic tumours with implanted fiducial marker.
52  Markov model mediator
(1 time)
Biomedical Engineering
(1 time)
--- 2004 Stochastic clustering for organizing distributed information sources.
53  material mapping method
(1 time)
Biomedical Engineering
(1 time)
FE (1 time)
SWF (1 time)
2016 The influence of the modulus-density relationship and the material mapping method on the simulated mechanical response of the proximal femur in side-ways fall loading configuration.
54  Maternal mortality and morbidity
(1 time)
Ethics
(1 time)
MDGs (1 time)
2012 Integrating interventions on maternal mortality and morbidity and HIV: a human rights-based framework and approach.
55  maximum monthly mean
(1 time)
Natural Science Disciplines
(1 time)
--- 2018 The bioeroding sponge Cliona orientalis will not tolerate future projected ocean warming.
56  Mayo Molecular Model
(1 time)
Hematology
(1 time)
CMML (1 time)
CPSS-Mol (1 time)
GFM (1 time)
2018 Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
57  MCP-1, Mip-1alpha, and Mip-2alpha
(1 time)
Immune System Diseases
(1 time)
MK2 (1 time)
2018 MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth.
58  Mean Motion Model
(1 time)
Biomedical Engineering
(1 time)
AVC (1 time)
PCA (1 time)
SMFP (1 time)
2017 Patient-specific respiratory motion estimation using Sparse Motion Field Presentation.
59  meaning maintenance model
(1 time)
Psychology
(1 time)
--- 2006 The meaning maintenance model: on the coherence of social motivations.
60  Medical Module Manager
(1 time)
Military Medicine
(1 time)
R2A (1 time)
0 The Role 2 Afloat custodian.
61  Medications and Mother's Milk
(1 time)
Nutritional Sciences
(1 time)
--- 2009 The identifying and counseling of breastfeeding women by pharmacists.
62  medium maturing middle
(1 time)
Botany
(1 time)
EML (1 time)
HD (1 time)
LMM (1 time)
2009 The distribution of japonica rice cultivars in the lower region of the Yangtze River valley is determined by its photoperiod-sensitivity and heading date genotypes.
63  medium-molar mass
(1 time)
Microbiology
(1 time)
DOC (1 time)
2006 Bacterial growth and community composition in fractions of dissolved organic carbon of different molar mass from interstitial water.
64  meta-metamaterial
(1 time)
Biophysics
(1 time)
--- 2018 Casimir repulsion in superparamagnetic metamaterial constructed by non-monodisperse nanoparticles.
65  metabolites--middle mass molecules
(1 time)
General Surgery
(1 time)
CIC (1 time)
1990 [Evaluation of the degree of ischemia of the lower extremities in arteriosclerosis obliterans based on the levels of toxic metabolites in the blood].
66  metal magnetic memory
(1 time)
Medicine
(1 time)
EMA (1 time)
TTM (1 time)
2013 High sensitive methods for health monitoring of compressor blades and fatigue detection.
67  metastatic meningeal melanomatosis
(1 time)
Neoplasms
(1 time)
CSF (1 time)
SCM (1 time)
1993 Intrathecal IgM response in disseminated cerebrospinal metastasis from malignant melanoma.
68  methotrexate, mitozantrone and mitomycin C
(1 time)
Neoplasms
(1 time)
ER (1 time)
2001 Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy.
69  methyl methacrylate monomer
(1 time)
Dentistry
(1 time)
--- 2010 Indirect bonding--do custom bases need a plastic conditioner? A randomised clinical trial.
70  MF with myeloid metaplasia
(1 time)
Pathology
(1 time)
BM (1 time)
MF (1 time)
2007 Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
71  Michaelis-Menten-Monod
(1 time)
Environmental Health
(1 time)
AMPA (1 time)
GLP (1 time)
2018 Analysis of glyphosate degradation in a soil microcosm.
72  microfluidic microcirculation mimetic
(1 time)
Biochemistry
(1 time)
--- 2016 Chemotherapy impedes invitro microcirculation and promotes migration of leukemic cells with impact on metastasis.
73  Military Medical Museum
(1 time)
Otolaryngology
(1 time)
--- 2012 [The magnitude and the structure of ENT sanitary losses in modern local armed conflicts].
74  mimicking myelofibrosis with myelocytic metaplasia
(1 time)
Genetics, Medical
(1 time)
PPMF (1 time)
PV (1 time)
2003 Karyotypic abnormalities in myelofibrosis following polycythemia vera.
75  Ming-Men mixture
(1 time)
Complementary Therapies
(1 time)
CORT (1 time)
CRF (1 time)
HPAT (1 time)
1995 [Effect of ming-men mixture on corticosterone-rats' neuro-endocrino-immunological network].
76  mini-mindfulness meditation
(1 time)
Medicine
(1 time)
MBST (1 time)
2017 Mindfulness: A New Paradigm of Psychosocial Care in the Palliative Care Setting in Southeast Asia.
77  miniature manipulator with a microelectrode
(1 time)
Neurology
(1 time)
--- 1991 Miniature manipulator with microelectrode for chronic recording of single units from freely-moving animals.
78  minicore-multicore myopathy
(1 time)
Neurology
(1 time)
--- 1991 The natural history of minicore-multicore myopathy.
79  minimum, maximum, and mean
(1 time)
Biosensing Techniques
(1 time)
E-Noses (1 time)
GRNN (1 time)
k-NN (1 time)
2017 A False Alarm Reduction Method for a Gas Sensor Based Electronic Nose.
80  Mitomycin C, melphalan, and methotrexate
(1 time)
Antineoplastic Agents
(1 time)
--- 1984 Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancer.
81  mitomycin-C and methotrexate
(1 time)
Neoplasms
(1 time)
--- 1991 A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
82  mitomycin-methotrexate-mitoxantrone
(1 time)
Antineoplastic Agents
(1 time)
CMF (1 time)
1996 Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy.
83  mitoxantrone, mitomycin-c and methotrexate
(1 time)
Medicine
(1 time)
LABC (1 time)
LRRT (1 time)
MRM (1 time)
1998 Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
84  mixed malignant mesothelioma
(1 time)
Cell Biology
(1 time)
EMM (1 time)
FNAB (1 time)
LSM (1 time)
1999 Cytopathology of malignant mesothelioma of the pleura in fine-needle aspiration biopsy.
85  mixed matrix hollow fiber membrane
(1 time)
Chemistry
(1 time)
--- 2018 Treatment of methylene blue containing wastewater by a cost-effective micro-scale biochar/polysulfone mixed matrix hollow fiber membrane: Performance and mechanism studies.
86  mixed Mediterranean-type meal
(1 time)
Sports Medicine
(1 time)
FA (1 time)
HSFAM (1 time)
2016 A single Mediterranean meal does not impair postprandial flow-mediated dilatation in healthy men with subclinical metabolic dysregulations.
87  mixed-model methodology
(1 time)
Veterinary Medicine
(1 time)
OLS (1 time)
1992 Classical and mixed-model analysis of an index selection experiment for fecundity in Drosophila melanogaster.
88  mixture missing mechanism
(1 time)
Pharmacology
(1 time)
MAR (1 time)
MCAR (1 time)
MNAR (1 time)
2012 Missing data mechanisms in a dose-finding adaptive trial.
89  MM metastases
(1 time)
Neoplasms
(1 time)
APC (1 time)
BMN (1 time)
CTL (1 time)
1995 In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity.
90  Model of Moral Motives
(1 time)
Psychology
(1 time)
--- 2013 Moral context matters: a reply to Graham.
91  moderated mediation model
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
HRQoL (1 time)
PLH (1 time)
2017 A Moderated Mediation Model of HIV-Related Stigma, Depression, and Social Support on Health-Related Quality of Life among Incarcerated Malaysian Men with HIV and Opioid Dependence.
92  modified marine medium
(1 time)
Biotechnology
(1 time)
CMC (1 time)
2010 Biosurfactant production and growth kinetics of bacteria in a designer marine medium: improved physiochemical properties.
93  Modified Mucus Method
(1 time)
Family Planning Services
(1 time)
CYP (1 time)
NFP (1 time)
ST/OM (1 time)
1994 Trial of a new method of natural family planning in Liberia.
94  Molecular Mayo Model
(1 time)
Hematology
(1 time)
CMML (1 time)
GFM (1 time)
2016 Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.
95  molecular mechanics method
(1 time)
Biochemistry
(1 time)
--- 1984 The X-ray investigation of 16 alpha,17 alpha-thiazolidine derivatives of delta 4- and delta 5-pregnanes and conformational analysis of their oxathiolane analog.
96  molecular memory modification
(1 time)
Ethics
(1 time)
--- 2015 The ethics of molecular memory modification.
97  molecular microbiological methods
(1 time)
Biotechnology
(1 time)
CM (1 time)
MIC (1 time)
MPN (1 time)
2017 Management and control of microbiologically influenced corrosion (MIC) in the oil and gas industry-Overview and a North Sea case study.
98  molecular modelling method
(1 time)
Biochemistry
(1 time)
FMN (1 time)
PVA (1 time)
2003 The effect of temperature on FMN absorption spectra in rigid poly(vinyl alcohol) matrices.
99  Monday morning miseries
(1 time)
Medicine
(1 time)
PEFR (1 time)
1991 [Immunologic response to microorganisms from a polluted ventilation system in a working environment].
100  monomer methylmethacrylate
(1 time)
Ophthalmology
(1 time)
--- 1987 Release and elimination of methylmethacrylate monomer after intraocular lens implantation.